The new European regulation 2017/745 on medical devices, entered into force on 25 May 2017 and repealing the former Directive 93/42 / EEC, It introduces important changes in the regulatory framework governing the placing on the European market for medical devices.
The seminar to be held at the headquarters of the laboratory CATAS Brianza in Lissone (MB) Thursday 20 September at 14.00 aims to frame the new legislative context in which are medical devices and the main changes introduced by the new regulation concerning verification of conformity of products and the obligations of operators.
The event attended by the dott. Andrea Giavon, Director of CATAS, Alberto Gelosa, responsible for CATAS Brianza and the dott. Roberto Passini, Director of Sicom Testing, test lab and certification of electrical products, electronic and radio products, dealing with the regulatory framework in the event that the products are integrated with control devices or motorized movements.